COVID-19: present and future challenges for dental practice

N Dar-Odeh, H Babkair, S Abu-Hammad… - International journal of …, 2020 - mdpi.com
COVID-19 was declared a pandemic by the World Health Organization, with a high fatality
rate that may reach 8%. The disease is caused by SARS-CoV-2 which is one of the …

Clostridioides difficile infection in inflammatory bowel disease: A clinical review

M Tang, C Wang, Y **a, J Tang, J Wang… - Expert Review of Anti …, 2024 - Taylor & Francis
Introduction Strong clinical data demonstrate that inflammatory bowel disease (IBD) is an
independent risk factor for Clostridiodes difficile infection (CDI) and suggest a globally …

Treatment with butyrate alleviates dextran sulfate sodium and Clostridium difficile-induced colitis by preventing activity of Th17 cells via regulation of SIRT1/mTOR in …

S Wang, W Deng, F Li, L **ang, P Lv, Y Chen - The Journal of Nutritional …, 2023 - Elsevier
Inflammatory bowel disease (IBD) patients are particularly vulnerable to infection with
Clostridium difficile infection (CDI). Available treatments of IBD with CDI have not effective …

Intestinal Microbiota in Elderly Inpatients with Clostridioides difficile Infection

B Vakili, A Fateh, H Asadzadeh Aghdaei… - Infection and drug …, 2020 - Taylor & Francis
Purpose The incidence of Clostridioides difficile infection (CDI) has been reported as 10-fold
higher among the elderly population than in young adults. The aim of this study was to …

Clostridioides difficile epidemiology in the Middle and the Far East

M Brajerova, J Zikova, M Krutova - Anaerobe, 2022 - Elsevier
Objectives Clostridioides difficile is an important pathogen of healthcare-associated
gastrointestinal infections. Recently, an increased number of C. difficile infection (CDI) …

Therapy used to promote disease remission targeting gut dysbiosis, in UC patients with active disease

HC Mirsepasi-Lauridsen - Journal of Clinical Medicine, 2022 - mdpi.com
Ulcerative colitis (UC) is a relapsing non-transmural chronic inflammatory disease of the
colon characterized by bloody diarrhea. The etiology of UC is unknown. The goal is to …

[HTML][HTML] Polysaccharide from Smilax glabra Roxb Mitigates Intestinal Mucosal Damage by Therapeutically Restoring the Interactions between Gut Microbiota and …

M Abaidullah, S La, M Liu, B Liu, Y Cui, Z Wang, H Sun… - Nutrients, 2023 - mdpi.com
Smilax glabra Roxb (S. glabra) is a conventional Chinese medicine that is mainly used for
the reliability of inflammation. However, bioactive polysaccharides from S. glabra (SGPs) …

The effect of a hydrolyzed protein diet on the fecal microbiota in cats with chronic enteropathy

A Kathrani, S Yen, JR Swann, EJ Hall - Scientific Reports, 2022 - nature.com
The effect of a hydrolyzed protein diet on the fecal microbiota has not been studied in feline
chronic enteropathy (CE). Our study aimed to (1) compare the fecal microbiota of cats with …

[HTML][HTML] Drug targeting of inflammatory bowel diseases by biomolecules

JC Antunes, CL Seabra, JM Domingues, MO Teixeira… - Nanomaterials, 2021 - mdpi.com
Inflammatory bowel disease (IBD) is a group of disabling, destructive and incurable immune-
mediated inflammatory diseases comprising Crohn's disease (CD) and ulcerative colitis …

Characterization of Gut Microbiota in Hospitalized Patients with Clostridioides difficile Infection

B Vakili, A Fateh, H Asadzadeh Aghdaei… - Current …, 2020 - Springer
Clostridioides difficile infection (CDI) is one of the most common causes of nosocomial
diarrhea in developed countries and the main cause in healthcare settings. This case …